4 models fit Honeywell Aerospace Inc. and they disagree: 1 of 4 land within 15% of the average.
Two or more of our models back this value.
Premium(i)Bronze56
Valued as a mature, profitable company: Discounted cash flow, P/E comparison, EV/EBITDA comparison, and Graham number.
ACCE opinionHoneywell Aerospace Inc. (HONA)
Fair value (4 models)
$147
ACCE price target
$168
Rating
Overvalued
Horizon
12 months
Fair value published on 21 Oct 2026, 11:06 CEST; previously $203 since 16 Oct 2026, 00:00 CEST.
ACCE price target published on 9 Aug 2026, 00:00 CEST.
Price used: $163, close of 23 Oct 2026.
Models: Discounted cash flow, P/E comparison, EV/EBITDA comparison, and Graham number.
Fair value: the average of the applicable valuation models (discounted cash flow, multiples, residual income, dividend discount, shareholder yield), each run on the latest financial statements and the market price shown. Opinion columns (fair value, target, rating) are shown apart from the data. Full methodology: acceinvestments.com/data/how-we-value-stocks
Conflicts of interest: The author holds no personal position in this security. General statement
Produced by ACCE Investments (acceinvestments.com)
Data
Price vs fair value
11.4% above
-10.2% to fair value
ACCE score
47
out of 100
Analysts
35% buy
17 covering
P/E
49.8x
forward 18.3x
Dividend yield
0.00%
Honeywell Aerospace Inc. in four questions
Plain answers, details below
Free accounts get 5 full stock pages a month, including the four answers.
Overview
ACCE thesis
Designs and manufactures avionics, propulsion systems, and mechanical components for commercial, defense, and business aviation platforms across the full aircraft lifecycle. The aerospace aftermarket is the core structural advantage here - long-tailed service agreements and sole-source positions on certified hardware create recurring revenue streams that new entrants cannot replicate without decades of FAA certification work. The commercial aviation recovery continues to pull through high-margin MRO demand, and defense budget momentum in Europe and the Middle East adds an incremental layer that wasn't in numbers two years ago. At a forward PE of 25x against 20.2% operating margins, the market is pricing this as a steady compounder rather than a re-rating story - which is fair, but a 42.8x trailing multiple against 6.8% revenue growth leaves little room for execution stumbles. ROE registering at zero is a red flag that needs a direct answer before this clears the bar for a concentrated position.